Valuation: Coloplast

Market Cap 94.1B 14.3B 12.59B 11.93B 10.77B 20.3B 1,371B 20.56B 143B 54.93B 701B 53.69B 52.52B 2,247B P/E 2026 *
27x
P/E 2027 * 16.1x
Enterprise Value 115B 17.4B 15.32B 14.52B 13.11B 24.7B 1,668B 25.02B 174B 66.84B 853B 65.33B 63.91B 2,734B EV / Sales 2026 *
3.97x
EV / Sales 2027 * 3.69x
Free-Float
63.42%
Yield 2026 *
4.88%
Yield 2027 * 5.18%
Manager TitleAgeSince
Chief Executive Officer 55 01/05/2026
Director of Finance/CFO 54 01/01/2006
Chief Operating Officer 59 05/09/2008
Director TitleAgeSince
Director/Board Member 79 13/12/2006
Director/Board Member 56 18/09/2009
Chairman 58 05/05/2025
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 14.3B
-1.33%-3.68%-27.06%+1.70% 171B
-0.36%-2.94%-9.46%+10.38% 110B
-1.01%+0.98%-25.19%-0.52% 106B
-0.69%-0.07%-47.78%-11.65% 75.99B
+1.48%-1.45%-2.05%+70.52% 57.3B
-0.53%-0.75%-6.83%-30.99% 48.76B
+3.44%+7.90%+19.12%+59.15% 50.19B
-0.16%+1.43%-16.03%+20.83% 41.14B
-0.18%-1.71%+30.10%-9.07% 32.56B
Average +0.03%-1.46%-9.46%+12.26% 77B
Weighted average by Cap. -0.34%-2.07%-16.07%+9.46%

Financials

2026 *2027 *
Net sales 28.86B 4.38B 3.86B 3.66B 3.3B 6.22B 420B 6.31B 43.77B 16.84B 215B 16.46B 16.11B 689B 30.81B 4.68B 4.12B 3.91B 3.53B 6.65B 449B 6.73B 46.73B 17.98B 229B 17.58B 17.19B 736B
Net income 3.55B 539M 475M 450M 406M 766M 51.7B 775M 5.38B 2.07B 26.43B 2.02B 1.98B 84.74B 5.85B 888M 782M 741M 669M 1.26B 85.17B 1.28B 8.87B 3.41B 43.54B 3.34B 3.26B 140B
Net Debt 20.4B 3.1B 2.73B 2.59B 2.34B 4.4B 297B 4.46B 30.95B 11.91B 152B 11.64B 11.39B 487B 19.59B 2.98B 2.62B 2.48B 2.24B 4.23B 285B 4.28B 29.71B 11.43B 146B 11.18B 10.93B 468B
Logo Coloplast
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - ostomy care products (35.5%): bags and equipment used following intestinal operations; - hygiene products (32.2%): urine bags, plugs, urinary testing systems and sets, etc.; - wound care and skincare products (14.1%): wound dressings, bandages, creams and gels; - interventional urology products (10%); - voice and respiratory care products (8.2%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.5%), the United States (23.5%), the United Kingdom (14%), France (10.1%), Germany (9.7%) and other (41.2%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA